Immunocompromised-Associated Pediatric Acute Respiratory Distress Syndrome: Experience From the 2016/2017 Pediatric Acute Respiratory Distress Syndrome Incidence and Epidemiology Prospective Cohort Study.

ABSTRACT:

Objectives

To characterize immunocompromised-associated pediatric acute respiratory distress syndrome (I-PARDS) and contrast it to PARDS.

Design

This is a secondary analysis of the 2016-2017 PARDS incidence and epidemiology (PARDIE) study, a prospective observational, cross-sectional study of children with PARDS.

Setting

Dataset of 145 PICUs across 27 countries.

Patients

During 10 nonconsecutive weeks (from May 2016 to June 2017), data about immunocompromising conditions (ICCs, defined as malignancy, congenital/acquired immunodeficiency, posttransplantation, or diseases requiring immunosuppression) were collected.

Interventions

None.

Measurements and main results

Of 708 subjects, 105 (14.8%) had ICC. Before the development of I-PARDS, those with I

SUBMITTER: Gertz SJ 

PROVIDER: S-EPMC10994753 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature